Henrik Almroth

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

Emmanuel Ekanem, Petr Neužil, Tobias Reichlin et al. · Nature Medicine · 2024 · 412 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +14

Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma

Ruzan Udumyan, Scott Montgomery, Fang Fang et al. · Cancer Research · 2017 · 110 citations

Medicine, Oncology, Pharmacology +16

Stress resilience and physical fitness in adolescence and risk of coronary heart disease in middle age

Cecilia Bergh, Ruzan Udumyan, Katja Fall et al. · Heart · 2015 · 71 citations · Full text

Medicine, Cardiology, Psychology +16

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

Henrik Almroth, Niklas Höglund, Kurt Boman et al. · European Heart Journal · 2008 · 65 citations · Full text

Medicine, Cardiology, Pharmacology +13